The article analyses data on clinical efficacy of the drug enterol in patients with chronic pancreatitis and chronic atropic gastritis. The use of enterol in a complex therapy has been shown to favour quick dispelling of the pain and dyspeptic syndromes, normalization of stools, elimination of intestinal dysbacteriosis or alleviation of its gravity.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring.
Clin Pharmacokinet
October 2024
Research and Development Directorate, Gedeon Richter Plc, Budapest, Hungary.
Background: Cariprazine is metabolised mainly by CYP3A4 and to a lesser extent by CYP2D6.
Aim: This study aimed to evaluate the effects of erythromycin, a moderate cytochrome P450 (CYP)3A4 inhibitor, on the pharmacokinetics of cariprazine in male patients with schizophrenia, and to assess the influence of CYP2D6 phenotypes on cariprazine metabolism.
Methods: Forty-two patients received oral doses of 1.
Effect of Mutant and Engineered High-Acetate-Producing var. Strains in Dextran Sodium Sulphate-Induced Colitis.
Nutrients
August 2024
TARGID, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, 3000 Leuven, Belgium.
Acetate-producing var. strains could exert improved effects on ulcerative colitis, which here, was preclinically evaluated in an acute dextran sodium sulphate induced model of colitis. Nine-week-old female mice were divided into 12 groups, receiving either drinking water or 2.
View Article and Find Full Text PDFEnhancing probiotic impact: engineering for optimal acetic acid production and gastric passage tolerance.
Appl Environ Microbiol
June 2024
NovelYeast bv, Bio-Incubator BIO4, Leuven-Heverlee, Belgium.
Article Synopsis
- Recent research delves into the probiotic potential of a microorganism, discovering unique mutations that lead to high acetic acid levels which inhibit bacterial growth.
- The newly engineered strain, ENT3, derived from the CMCN I-745 strain, produces higher acetic acid concentrations without increased sensitivity to acidity.
- Findings suggest that this enhanced acetic acid production can improve antimicrobial effects against gut pathogens and possibly enhance the probiotic action of the microorganism in healthy mice.
New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Appl Microbiol Biotechnol
January 2024
Excellent Research Laboratory for Yeast Innovation, Division of Biochemical Technology, School of Bioresources and Technology, King Mongkut's University of Technology Thonburi, Bangkok, Thailand.
Evolutionary engineering experiments, in combination with omics technologies, revealed genetic markers underpinning the molecular mechanisms behind acetic acid stress tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii. Here, compared to the ancestral Ent strain, evolved yeast strains could quickly adapt to high acetic acid levels (7 g/L) and displayed a shorter lag phase of growth.
View Article and Find Full Text PDFPropolis ethanolic extract has double-face effect on the planktonic growth and biofilm formation of some commercial probiotics.
Saudi J Biol Sci
January 2021
Department of General and Environmental Microbiology, University of Pécs, Faculty of Sciences, Pécs, Hungary.
This study investigated the effect of propolis ethanolic extract (PEE) on planktonic growth and biofilm forming abilities of five commercial probiotics (Enterol, Protexin, Normaflore, BioGaia and Linex). Broth microdilution method was used to investigate the susceptibility of the microbes of five commercial probiotics to PEE. Crystal violet assay was used for the quantitative assessment of biofilm formation and mature biofilm eradication tests.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!